75 related articles for article (PubMed ID: 2673848)
1. Recovery from polyclonal tolerance: simulation analysis.
Dolezal J; Fontalin LN; Kondratieva TK; Hraba T
Folia Biol (Praha); 1989; 35(3):164-70. PubMed ID: 2673848
[TBL] [Abstract][Full Text] [Related]
2. Polyclonal B cell anergy induced by bacterial lipopolysaccharide and cyclophosphamide.
Fontalin LN; Kondratieva TK; Kondratieva IA; Smirnova IN; Mikheeva NV
Folia Biol (Praha); 1988; 34(2):72-83. PubMed ID: 3294050
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of polyclonal tolerance induced by lipopolysaccharide and cyclophosphamide].
Kondrat'eva TK; Fontalin LN; Mikheeva NV; Golan' V
Biull Eksp Biol Med; 1987 Oct; 104(10):483-5. PubMed ID: 3118987
[TBL] [Abstract][Full Text] [Related]
4. Studies on lipopolysaccharide-induced polyclonal B cell activity in mice tolerized by sheep red blood cells and cyclophosphamide.
Fontalin LN; Kondratieva TK; Kondratieva IA; Sidorova EV; Megrabyan TB
Folia Biol (Praha); 1985; 31(5):321-32. PubMed ID: 3905443
[TBL] [Abstract][Full Text] [Related]
5. Simulation analysis of the mechanism of escape from immunoglobulin suppression.
Dolezal J; Hraba T
Folia Biol (Praha); 1988; 34(5):330-5. PubMed ID: 3266602
[TBL] [Abstract][Full Text] [Related]
6. Implications of a mathematical model for the role of lymphocytes with different lifespans in the recovery from tolerance.
Dolezal J; Hraba T
Folia Biol (Praha); 1987; 33(5):356-62. PubMed ID: 2446934
[TBL] [Abstract][Full Text] [Related]
7. A contribution to mathematical modelling of immunological tolerance.
Dolezal J; Hraba T
Arch Immunol Ther Exp (Warsz); 1988; 36(1):23-30. PubMed ID: 3266071
[TBL] [Abstract][Full Text] [Related]
8. T helper cell inclusion into the mathematical model of immunological tolerance.
Dolezal J; Hraba T
Folia Biol (Praha); 1984; 30(6):426-31. PubMed ID: 6240417
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide intensifies the acquisition of allergic contact dermatitis in mice rendered B-cell deficient by heterologous anti-IgM antisera.
Maguire HC; Faris L; Weidanz W
Immunology; 1979 Jun; 37(2):367-72. PubMed ID: 313902
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
Majlessi L; Bordenave G
Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
[TBL] [Abstract][Full Text] [Related]
12. The immune response of mice to Serratia marcescens LPS or intact bacteria.
Field C; Allen JL; Friedman H
J Immunol; 1970 Jul; 105(1):193-203. PubMed ID: 4912960
[No Abstract] [Full Text] [Related]
13. A technique for inducing B-cell ablation in chickens by in ovo injection of cyclophosphamide.
Reynolds DL; Maraqa AD
Avian Dis; 1999; 43(3):367-75. PubMed ID: 10494404
[TBL] [Abstract][Full Text] [Related]
14. Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.
Stevenson HC; Fauci AS
Immunology; 1980 Mar; 39(3):391-7. PubMed ID: 7002766
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages.
Blanchard DK; Djeu JY; Klein TW; Friedman H; Stewart WE
J Immunol; 1986 Feb; 136(3):963-70. PubMed ID: 2867114
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory effects of bacterial lipopolysaccharide on human B lymphocyte activation in vitro.
Zabala C; Lipsky PE
J Immunol; 1982 Dec; 129(6):2496-503. PubMed ID: 6982929
[No Abstract] [Full Text] [Related]
17. Polyclonal activation of the murine immune system by an antibody to IgD. VII. Demonstration of the role of nonantigen-specific T help in in vivo B cell activation.
Finkelman FD; Smith J; Villacreses N; Metcalf ES
J Immunol; 1984 Aug; 133(2):550-5. PubMed ID: 6203966
[TBL] [Abstract][Full Text] [Related]
18. Membrane defects of the tolerant B cell. IV. Failure to accelerate antigen receptor loss.
Meucci V; Ashman RF
J Immunol; 1986 Apr; 136(7):2339-41. PubMed ID: 3485147
[TBL] [Abstract][Full Text] [Related]
19. Delineation of tolerance-sensitive and tolerance-insensitive B cells in normal and immune defective mice.
McKearn JP; Quintáns J
J Immunol; 1980 Jan; 124(1):77-80. PubMed ID: 6965299
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of Francisella tularensis lipopolysaccharide on B lymphocytes.
Rahhal RM; Vanden Bush TJ; McLendon MK; Apicella MA; Bishop GA
J Leukoc Biol; 2007 Oct; 82(4):813-20. PubMed ID: 17634278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
